Quick Answer
TANDEM DIABETES CARE INC reported Gross Profit of $546.01 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed an increase of +11.5% in Gross Profit from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2015: $5.51 million | Q4 2015: $13.46 million | Q1 2016: $6.93 million | Q2 2016: $8.18 million | Q3 2016: -$1.58 million | Q4 2016: $10.07 million | Q1 2017: $6.75 million | Q2 2017: $8.00 million | Q3 2017: $11.87 million | Q4 2017: $17.47 million | Q1 2018: $11.40 million | Q2 2018: $15.09 million | Q3 2018: $21.80 million | Q4 2018: $41.54 million | Q1 2019: $33.35 million | Q2 2019: $49.90 million | Q3 2019: $50.68 million | Q4 2019: $60.27 million | Q1 2020: $50.26 million | Q2 2020: $54.39 million | Q3 2020: $65.31 million | Q4 2020: $90.56 million | Q1 2021: $73.29 million | Q2 2021: $92.45 million | Q3 2021: $96.75 million | Q4 2021: $113.73 million | Q1 2022: $91.09 million | Q2 2022: $101.95 million | Q3 2022: $104.43 million | Q4 2022: $115.52 million | Q1 2023: $82.91 million | Q2 2023: $101.74 million | Q3 2023: $89.75 million | Q4 2023: $93.30 million | Q1 2024: $94.67 million | Q2 2024: $112.79 million | Q3 2024: $124.65 million | Q4 2024: $157.46 million | Q1 2025: $118.41 million | Q2 2025: $125.86 million | Q3 2025: $134.29 million | Q4 2025: $167.46 million.
- Over the full 14 years of available data (2012 to 2025), TANDEM DIABETES CARE INC's Gross Profit has grown by 40,605.5%.
- Historical annual values: Fiscal year 2025: $546.01 million | Fiscal year 2024: $489.57 million | Fiscal year 2023: $367.69 million | Fiscal year 2022: $412.99 million | Fiscal year 2021: $376.22 million | Fiscal year 2020: $260.52 million | Fiscal year 2019: $194.21 million | Fiscal year 2018: $89.82 million | Fiscal year 2017: $44.09 million | Fiscal year 2016: $23.59 million | Fiscal year 2015: $26.58 million | Fiscal year 2014: $15.25 million | Fiscal year 2013: $6.17 million | Fiscal year 2012: -$1.35 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: